Growth Metrics

Coherus Oncology (CHRS) Prepaid Assets: 2013-2025

Historic Prepaid Assets for Coherus Oncology (CHRS) over the last 12 years, with Sep 2025 value amounting to $8.7 million.

  • Coherus Oncology's Prepaid Assets fell 38.63% to $8.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.7 million, marking a year-over-year decrease of 38.63%. This contributed to the annual value of $10.2 million for FY2024, which is 56.87% down from last year.
  • Coherus Oncology's Prepaid Assets amounted to $8.7 million in Q3 2025, which was down 25.74% from $11.7 million recorded in Q2 2025.
  • In the past 5 years, Coherus Oncology's Prepaid Assets registered a high of $23.7 million during Q4 2023, and its lowest value of $8.7 million during Q3 2025.
  • In the last 3 years, Coherus Oncology's Prepaid Assets had a median value of $14.2 million in 2024 and averaged $15.2 million.
  • Per our database at Business Quant, Coherus Oncology's Prepaid Assets skyrocketed by 67.28% in 2022 and then tumbled by 56.87% in 2024.
  • Over the past 5 years, Coherus Oncology's Prepaid Assets (Quarterly) stood at $13.7 million in 2021, then surged by 67.28% to $22.9 million in 2022, then increased by 3.41% to $23.7 million in 2023, then plummeted by 56.87% to $10.2 million in 2024, then plummeted by 38.63% to $8.7 million in 2025.
  • Its Prepaid Assets was $8.7 million in Q3 2025, compared to $11.7 million in Q2 2025 and $15.9 million in Q1 2025.